Hedge Fund Replicators Gaining Momentum

December 27th, 2009
| More
Hedge fund replicators that attempt to mimic the returns of hedge fund indices are gaining some traction. The replicators have lower fees (1%-2%) and are commonly structured as ETFs, mutual funds or separate accounts. According to a recent Wall Street Journal article, some of the early leaders in the space are: Goldman Sachs Asset Management ($2bn), State Street Global Advisors ($400mm), AlphaSimplex Group ($209mm), and IndexIQ ($200mm) in assets under management (AUM).

In the article, Dr. Andrew Lo is quoted as saying “we view what we're doing as what Jack Bogle did at Vanguard in the 1970s” to the indexed mutual fund industry. Dr. Lo is the founder, Chairman and Chief Scientific Officer of AlphaSimplex Group, which manages the Natixis ASG Global Alternatives mutual fund. AlphaSimplex uses forwards and futures to achieve “hedge fund beta replication.” Dr. Lo is also a tenured quantitative finance professor at the Massachusetts Institute of Technology (M.I.T.).
For Detailed Investor Profiles on these Investors, click below:
AlphaSimplex Group
Related People: Dr. Andrew W. Lo
Related Entities: Massachusetts Institute of Technology (M.I.T.); Natixis ASG Global Alternatives; Natixis Global Asset Management
Related Article Tags: Multi-Strategy, Long Short, Equity, Debt and Global Macro Hedge Fund News

Add a Comment

More Recent Headlines

John Burbank’s Passport Capital buys physical Gold Bricks

DE Shaw & Co plans to launch Heliant Hedge Fund in Q1 of 2010

Fortress Investment Group sues law firm connected to Dreier Ponzi scheme

A Hedge Fund Lesson for the Rest of Us

Crispin Odey earns almost $50 million from UK banking industry

KKR’s use of Warren Buffett’s strategy off to a rocky start

Coal for Christmas, SEC Freezes Accounts of Frenchmen for Sanofi-Aventis – Chattem trades

Templeton Asset Management outlines lack of confidence in Taro Pharmaceuticals

Chelsea Clinton engaged to 3G Capital Management’s Marc Mezvinsky

Adaptec CEO replaced by Steel Partners MD John Quicke